|
CA2894157A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
WO2014100716A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
JP2016505000A
(ja)
|
2012-12-21 |
2016-02-18 |
エピザイム，インコーポレイティド |
Ｐｒｍｔ５阻害剤およびその使用
|
|
MY199894A
(en)
|
2012-12-21 |
2023-11-27 |
Epizyme Inc |
Prmt5 inhibitors and uses thereof
|
|
JP2016505002A
(ja)
|
2012-12-21 |
2016-02-18 |
エピザイム，インコーポレイティド |
ジヒドロイソキノリンまたはテトラヒドロイソキノリンを含有するｐｒｍｔ５阻害剤およびその使用
|
|
WO2014144659A1
(en)
|
2013-03-14 |
2014-09-18 |
Epizyme, Inc. |
Pyrazole derivatives as prmt1 inhibitors and uses thereof
|
|
AU2014260433A1
(en)
|
2013-03-14 |
2015-09-10 |
Epizyme, Inc. |
Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
|
|
EP2970136A1
(en)
|
2013-03-14 |
2016-01-20 |
Epizyme, Inc. |
Arginine methyl transferase inhibtors and uses thereof
|
|
SG11201506972PA
(en)
|
2013-03-14 |
2015-10-29 |
Epizyme Inc |
Arginine methyltransferase inhibitors and uses thereof
|
|
US9120757B2
(en)
|
2013-03-14 |
2015-09-01 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
|
WO2014153208A1
(en)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
|
KR20160003647A
(ko)
|
2013-03-15 |
2016-01-11 |
에피자임, 인코포레이티드 |
Carm1 억제제 및 이의 용도
|
|
EP2970266B1
(en)
|
2013-03-15 |
2018-01-31 |
Epizyme, Inc. |
1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
TWI659021B
(zh)
|
2013-10-10 |
2019-05-11 |
亞瑞克西斯製藥公司 |
Ｋｒａｓ ｇ１２ｃ之抑制劑
|
|
CA2953572A1
(en)
|
2014-08-04 |
2016-02-11 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
MA52119A
(fr)
|
2015-10-19 |
2018-08-29 |
Ncyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
|
PT3377488T
(pt)
|
2015-11-19 |
2022-11-21 |
Incyte Corp |
Compostos heterocíclicos como imunomoduladores
|
|
SI3394033T1
(sl)
|
2015-12-22 |
2021-03-31 |
Incyte Corporation |
Heterociklične spojine kot imunomodulatorji
|
|
WO2017192961A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
EP3464279B1
(en)
|
2016-05-26 |
2021-11-24 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
PL3472167T3
(pl)
|
2016-06-20 |
2022-12-19 |
Incyte Corporation |
Związki heterocykliczne jako immunomodulatory
|
|
EP3484866B1
(en)
|
2016-07-14 |
2022-09-07 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
ES2941716T3
(es)
|
2016-08-29 |
2023-05-25 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
|
CA3042700A1
(en)
|
2016-11-07 |
2018-05-11 |
University Of Massachusetts |
Therapeutic targets for facioscapulohumeral muscular dystrophy
|
|
US20180179201A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
WO2018119286A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
|
KR102696516B1
(ko)
|
2016-12-22 |
2024-08-22 |
인사이트 코포레이션 |
면역조절제로서의 벤조옥사졸 유도체
|
|
EP3558973B1
(en)
|
2016-12-22 |
2021-09-15 |
Incyte Corporation |
Pyridine derivatives as immunomodulators
|
|
MY197501A
(en)
|
2016-12-22 |
2023-06-19 |
Incyte Corp |
Tetrahydro imidazo[4,5-c]pyridine derivatives as pd-l1 internalization inducers
|
|
WO2018140512A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
Fused bicyclic benzoheteroaromatic compounds and methods of use thereof
|
|
US11279689B2
(en)
|
2017-01-26 |
2022-03-22 |
Araxes Pharma Llc |
1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer
|
|
WO2018140514A1
(en)
|
2017-01-26 |
2018-08-02 |
Araxes Pharma Llc |
1-(6-(3-hydroxynaphthalen-1-yl)quinazolin-2-yl)azetidin-1-yl)prop-2-en-1-one derivatives and similar compounds as kras g12c inhibitors for the treatment of cancer
|
|
US11358959B2
(en)
|
2017-01-26 |
2022-06-14 |
Araxes Pharma Llc |
Benzothiophene and benzothiazole compounds and methods of use thereof
|
|
EP3573967A1
(en)
|
2017-01-26 |
2019-12-04 |
Araxes Pharma LLC |
Fused hetero-hetero bicyclic compounds and methods of use thereof
|
|
KR102007135B1
(ko)
|
2017-03-20 |
2019-08-02 |
포르마 세라퓨틱스 인크. |
피루베이트 키나제 (pkr) 활성화제로서의 피롤로피롤 조성물
|
|
CN110831933A
(zh)
|
2017-05-25 |
2020-02-21 |
亚瑞克西斯制药公司 |
喹唑啉衍生物作为突变kras、hras或nras的调节剂
|
|
CA3063440A1
(en)
|
2017-05-25 |
2018-11-29 |
Araxes Pharma Llc |
Covalent inhibitors of kras
|
|
EP4212529B1
(en)
|
2018-03-30 |
2025-01-29 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
|
FI4219492T3
(fi)
|
2018-05-11 |
2025-02-17 |
Incyte Corp |
Heterosyklisiä yhdisteitä immunomodulaattoreina
|
|
EP3829580A1
(en)
*
|
2018-08-01 |
2021-06-09 |
Araxes Pharma LLC |
Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer
|
|
EP3852791B1
(en)
|
2018-09-19 |
2024-07-03 |
Novo Nordisk Health Care AG |
Activating pyruvate kinase r
|
|
US20200129485A1
(en)
|
2018-09-19 |
2020-04-30 |
Forma Therapeutics, Inc. |
Treating sickle cell disease with a pyruvate kinase r activating compound
|
|
KR20220027216A
(ko)
|
2019-06-28 |
2022-03-07 |
에이엘에스 테라피 디벨럽먼트 인스티튜트 |
디펩타이드 반복 단백질의 억제
|
|
CA3150434A1
(en)
|
2019-08-09 |
2021-02-18 |
Incyte Corporation |
Salts of a pd-1/pd-l1 inhibitor
|
|
US20220378756A1
(en)
|
2019-09-19 |
2022-12-01 |
Forma Therapeutics, Inc. |
Activating pyruvate kinase r
|
|
AR120109A1
(es)
|
2019-09-30 |
2022-02-02 |
Incyte Corp |
Compuestos de pirido[3,2-d]pirimidina como inmunomoduladores
|
|
IL292524A
(en)
|
2019-11-11 |
2022-06-01 |
Incyte Corp |
Salts and crystalline forms of a pd-1/pd-l1 inhibitor
|
|
WO2021188828A1
(en)
*
|
2020-03-18 |
2021-09-23 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating cancer by inhibiting carm1
|
|
US11780836B2
(en)
|
2020-11-06 |
2023-10-10 |
Incyte Corporation |
Process of preparing a PD-1/PD-L1 inhibitor
|
|
WO2022099075A1
(en)
|
2020-11-06 |
2022-05-12 |
Incyte Corporation |
Crystalline form of a pd-1/pd-l1 inhibitor
|
|
PE20231438A1
(es)
|
2020-11-06 |
2023-09-14 |
Incyte Corp |
Proceso para hacer un inhibidor de pd-1/pd-l1 y sales y formas cristalinas del mismo
|
|
US12128035B2
(en)
|
2021-03-19 |
2024-10-29 |
Novo Nordisk Health Care Ag |
Activating pyruvate kinase R
|